SCHEMBL26212539

SCHEMBL26212539

CCCC(NC(=O)OCCCCn1cnc2c(N)nc(Cl)nc21)c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 11/20 0.42
▸ TMIGD3 P0DMS9 3/20 0.40
▸ ADORA2A P29274 3/20 0.40
▸ ADORA1 P30542 3/20 0.40
▸ ADORA2B P29275 1/20 0.39
▸ HDAC2 Q92769 10/20 0.38
▸ HDAC3 O15379 9/20 0.38
▸ HDAC4 P56524 9/20 0.38
▸ HDAC7 Q8WUI4 9/20 0.38
▸ HDAC10 Q969S8 9/20 0.38
▸ HDAC11 Q96DB2 9/20 0.38
▸ HDAC8 Q9BY41 9/20 0.38
▸ HDAC6 Q9UBN7 9/20 0.38
▸ HDAC9 Q9UKV0 9/20 0.38
▸ HDAC5 Q9UQL6 9/20 0.38
▸ NCOR2 Q9Y618 3/20 0.38
▸ YTHDC1 Q96MU7 1/20 0.38
▸ PDE8A O60658 2/20 0.37
▸ SERPINA3 P01011 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19575639 1.00 HDAC1 (0.42) HDAC1TMIGD3ADORA2AADORA1ADORA2B
SCHEMBL20975164 0.97 HDAC1 (0.43) HDAC1TMIGD3ADORA2AADORA1ADORA2B
SCHEMBL26212223 0.92 TMIGD3 (0.41) HDAC1TMIGD3ADORA2AADORA1ADORA2B
SCHEMBL19575371 0.92 TMIGD3 (0.41) HDAC1TMIGD3ADORA2AADORA1ADORA2B
SCHEMBL19575642 0.90 SERPINA3 (0.47) HDAC1TMIGD3ADORA2AADORA1ADORA2B
SCHEMBL26212252 0.90 SERPINA3 (0.47) HDAC1TMIGD3ADORA2AADORA1ADORA2B
SCHEMBL26212177 0.87 ADORA2A (0.49) ADORA2AADORA1ADORA2B
SCHEMBL19574920 0.87 ADORA2A (0.49) ADORA2AADORA1ADORA2B
SCHEMBL26224146 0.84 ALDH1A1 (0.37) TMIGD3ADORA2AADORA1
SCHEMBL19575724 0.82 PPARG (0.37) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3452477-B1 ADENINE DERIVATIVES AS PROTEIN KINASE INHIBITORS B C I PHARMA (BE) 2023-09-13 — — EP disclosed
Send feedback